Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Alpha-foetoprotein and/or liver ultrasonography for screening of hepatocellular carcinoma in patients with chronic hepatitis B

Published:2012-09-12 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Aghoram Rajeswari¹,Cai Pin²,Dickinson James A³

Affiliation:

1. University of Calgary; Department of Family Medicine; 3330 Hospital drive NW Calgary Alberta Canada T2N 1M7

2. Calgary Institute of Population & Public Health; 3280 Hospital Drive NW Calgary Alberta Canada T2N 4Z6

3. University of Calgary; Family Medicine and Community Health Sciences; G012, Health Sciences Centre 3300 Hospital Dr NW Calgary Alberta Canada T2N 4N1

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD002799.pub2/fullpdf

Reference56 articles.

1. Screening for hepatocellular carcinoma in chronic carriers of hepatitis B: incidence and prevalence of hepatocellular carcinoma in a North American urban population;Sherman;Hepatology,1995

2. Hepatocellular carcinoma surveillance with 4 versus 12 months interval for patients with chronic viral hepatitis - a randomized community study;Wang;Hepatology,2011

3. Randomized controlled prospective study of secondary prevention for primary liver cancer;Yang;Zhonghua Yi Xue Za Zhi,1999

4. Screening and early diagnosis of primary liver cancer;Yang;Chinese Journal of Hepatology,1999

5. A prospective study of early detection for primary liver cancer;Yang;Zhanghua Zhong Liu Za Zhi [Chinese Journal of Oncology],1996

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benefits and harms of screening for hepatocellular carcinoma in high-risk populations: systematic review and meta-analysis;Journal of the National Cancer Center;2023-09

2. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma;Journal of Liver Cancer;2023-03-31

3. A synthesis of evidence for cancer-specific screening interventions: A Preventive Medicine Golden Jubilee Review;Preventive Medicine;2023-02

4. Role of CA 19.9 and CEA in predicting diagnosis in hepatocellular carcinoma;Journal of Cancer Research and Therapeutics;2023

5. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma;Clinical and Molecular Hepatology;2022-10-01